TSX Shariah screener · October 2026

Is Curaleaf Holdings, Inc. (CURA) Halal?

FAIL

Curaleaf Holdings, Inc. · TSX: CURA · Healthcare

The short answer

Curaleaf Holdings, Inc. (TSX: CURA) is a FAIL. The business gate fails: Curaleaf is a vertically integrated cannabis multi-state operator — 100% of revenue is cannabis, and the company itself states only about 60% of its US business is medical, i.e. roughly 40% is adult-use recreational cannabis, far above the ~5% threshold for a prohibited segment. The financial gates pass on their own: interest-bearing debt of US$611.5M is about 21.4% of the ~US$2.86B market cap (264.9M shares × C$15.38, September 29, 2026), under the ~33% ceiling, and separately disclosed interest income of US$149K is about 0.04% of Q2 2026 revenue, under the ~5% ceiling — but the business screen is decisive. Musaffa independently rates it not halal. This is a rules-based screen, not a religious ruling.

Gate 1 — Business activity: FAIL

Curaleaf Holdings, Inc. is a vertically integrated cannabis multi-state operator: it cultivates, manufactures, wholesales, and retails cannabis through 170+ dispensaries across about 18 US states, plus international operations (UK, Germany, Poland, and others). Q2 2026 revenue was US$340.1M (domestic retail US$224.4M, domestic wholesale US$64.0M, international retail US$16.4M, international wholesale US$31.9M) — all of it cannabis. The company itself states about 60% of its US business is medical, i.e. roughly 40% is adult-use recreational cannabis — far above the ~5% threshold for a prohibited segment. (Curaleaf graduated from the CSE to the TSX on December 14, 2023 and trades as TSX: CURA in CAD plus OTCQX: CURLF in USD.) The business gate fails, and that is decisive.

Gate 2 — Debt and cash: PASS (but moot)

Outstanding interest-bearing debt at June 30, 2026 (Q2 2026 results) was US$611.5M (net of unamortized debt discounts and deferred financing fees). Against a market cap of ~US$2.86B (264.9M shares × C$15.38, September 29, 2026, TSX; converted at ~0.70 USD/CAD), that is about 21.4% — under the ~33% ceiling. Cash and cash equivalents (including restricted cash) were US$107.0M, about 3.7% of market cap — under the ~33% guideline. The debt gate passes on its own, but it does not rescue the failed business screen.

Gate 3 — Non-compliant income: PASS (but moot)

The Q2 2026 condensed statements of operations separately disclose “Interest income” of US$149K — not netted against expense — against revenue of US$340.1M, about 0.04%, under the ~5% ceiling. (Six-month interest income was US$361K on US$664.3M revenue.) The income gate passes on its own, but it does not rescue the failed business screen.

Key figures used

FAIL — business gate fails decisively (October 2026 screen)
Business: vertically integrated cannabis MSO — cultivation, manufacturing, wholesale, 170+ dispensaries (~18 US states) + international; 100% of revenue is cannabis; ~40% of US business is adult-use recreational (company disclosure: ~60% medical)
Debt: US$611.5M outstanding (Jun 30, 2026) ≈ 21.4% of ~US$2.86B market cap vs ~33% ceiling (passes on its own)
Income: ≈0.04% — separately disclosed “Interest income” US$149K ÷ Q2 2026 revenue US$340.1M vs ~5% ceiling (passes on its own)
Cash: US$107.0M (incl. restricted) ≈ 3.7% of market cap
Third-party: Musaffa rates CURLF not halal (AAOIFI, Oct 2026) — agrees with our FAIL; no public Zoya/ShariaPortfolio coverage found
Caveat: Q3 2026 results expected ~November 3, 2026 — figures should be refreshed then

Frequently asked questions

Is Curaleaf Holdings (CURA) halal?

Our October 2026 screen gives Curaleaf Holdings, Inc. (TSX: CURA) a FAIL. The business gate fails: Curaleaf is a vertically integrated cannabis multi-state operator — 100% of its revenue is cannabis, and the company itself states only about 60% of its US business is medical, i.e. roughly 40% is adult-use recreational cannabis, far above the 5% threshold for a prohibited segment. The financial gates pass (debt about 21.4% of market cap; interest income about 0.04% of revenue), but the business screen is decisive. Musaffa independently rates it not halal. This is a rules-based screen, not a religious ruling.

What does Curaleaf Holdings do?

Curaleaf is a vertically integrated cannabis multi-state operator: it cultivates, manufactures, wholesales, and retails cannabis through 170+ dispensaries across about 18 US states, plus international operations (UK, Germany, Poland, and others). Q2 2026 revenue was US$340.1M (domestic retail US$224.4M, domestic wholesale US$64.0M, international retail US$16.4M, international wholesale US$31.9M). All revenue is cannabis.

How much debt does Curaleaf Holdings have?

At June 30, 2026 (Q2 2026 results), outstanding interest-bearing debt was US$611.5M (net of unamortized debt discounts and deferred financing fees). Against a market cap of ~US$2.86B (264.9M shares × C$15.38, September 29, 2026, TSX; converted at ~0.70 USD/CAD), that is about 21.4% — under the ~33% ceiling, so the debt gate passes on its own. Cash and equivalents (including restricted cash) were US$107.0M, about 3.7% of market cap.

Does Curaleaf earn interest income?

Very little, and it is separately disclosed. The Q2 2026 condensed statements of operations carry an “Interest income” line of US$149K (not netted against expense), against revenue of US$340.1M — about 0.04%, under the ~5% ceiling. The income gate passes on its own.

What do third-party Shariah screeners say about Curaleaf?

Musaffa covers CURLF and currently rates it not halal under AAOIFI methodology (page current as of October 2026), which agrees with our FAIL. No public Zoya or ShariaPortfolio coverage page for CURA/CURLF was found — their screening data sits behind app logins, so their status is honestly unknown rather than assumed.

Sources

Screened 2026-10-01 from published company figures and market data. Figures change; this page is educational, not financial advice and not a religious ruling.